Iasis Molecular Sciences Awarded $1.25 Million for Antimicrobial Catheter

Local company Iasis Molecular Sciences Corporation (ISMC) has been awarded $1.25 Million by the Congressionally Directed Medical Research Program's Spinal Cord Injury Research Program.

The grant will allow Iasis to manufacture and validate Iasis' novel composite silicone rubber catheter for regulatory submission. The catheter is wholly antimicrobial (tip, balloon, main body) which sets it apart from today's products that rely on antimicrobial coatings, said David Vachon, ISMC CEO.

This funding aligns with and extends the development of IMSC's model materials platform and complements recent awards from the National Heart, Lung and Blood Institute at NIH ($225,000) and the Centers for Disease Control and Prevention ($225,000). HSSA also has provided financial grants to Iasis.